Ivosidenib for IDH1-mutant cholangiocarcinoma

被引:0
|
作者
Baker, Holly
机构
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:647 / 647
页数:1
相关论文
共 50 条
  • [11] Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan
    Chen, Kuei-An
    Huang, Wei-Ming
    Chen, Eric Yi-Ting
    Ho, Pei-Kuan
    Chueh, Chen-Han
    Wen, Yu-Wen
    Chen, Ming-Huang
    Chiang, Nai-Jung
    Tsai, Yi-Wen
    BMC CANCER, 2024, 24 (01)
  • [12] COST-EFFECTIVENESS ANALYSIS OF IVOSIDENIB VERSUS CHEMOTHERAPY FOR PREVIOUSLY TREATED IDH1-MUTANT ADVANCED INTRAHEPATIC CHOLANGIOCARCINOMA IN TAIWAN
    Chen, K. A.
    Huang, W. M.
    Chen, E. Y. T.
    Ho, P. K.
    Chiang, N. J.
    Tsai, Y. W.
    VALUE IN HEALTH, 2023, 26 (06) : S1 - S2
  • [13] INCREASED SUSCEPTIBILITY TO BET INHIBITION IN IDH1-MUTANT INTRAHEPATIC CHOLANGIOCARCINOMA
    Fujiwara, Hiroaki
    Tateishi, Keisuke
    Kato, Hiroyuki
    Nakatsuka, Takuma
    Tanaka, Yasuo
    Ijichi, Hideaki
    Koike, Kazuhiko
    GASTROENTEROLOGY, 2019, 156 (06) : S771 - S771
  • [14] IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
    Khurshed, Mohammed
    Aarnoudse, Niels
    Hulsbos, Renske
    Hira, Vashendriya V. V.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    Molenaar, Remco J.
    van Noorden, Cornelis J.
    FASEB JOURNAL, 2019, 33
  • [15] IDH1-mutant cancer cells are sensitive to cisplatin and an IDH1-mutant inhibitor counteracts this sensitivity
    Khurshed, Mohammed
    Aarnoudse, Niels
    Hulsbos, Renske
    Hira, Vashendriya V. V.
    van Laarhoven, Hanneke W. M.
    Wilmink, Johanna W.
    Molenaar, Remco J.
    van Noorden, Cornelis J. F.
    FASEB JOURNAL, 2018, 32 (11): : 6344 - 6352
  • [16] Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML
    Choe, Sung
    Wang, Hongfang
    DiNardo, Courtney D.
    Stein, Eytan M.
    de Botton, Stephane
    Roboz, Gail J.
    Altman, Jessica K.
    Mims, Alice S.
    Watts, Justin M.
    Pollyea, Daniel A.
    Fathi, Amir T.
    Tallman, Martin S.
    Kantarjian, Hagop M.
    Stone, Richard M.
    Quek, Lynn
    Konteatis, Zenon
    Dang, Lenny
    Nicolay, Brandon
    Nejad, Parham
    Liu, Guowen
    Zhang, Vickie
    Liu, Hua
    Goldwasser, Meredith
    Liu, Wei
    Marks, Kevin
    Bowden, Chris
    Biller, Scott A.
    Attar, Eyal C.
    Wu, Bin
    BLOOD ADVANCES, 2020, 4 (09) : 1894 - 1905
  • [17] Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
    Ingo K. Mellinghoff
    Min Lu
    Patrick Y. Wen
    Jennie W. Taylor
    Elizabeth A. Maher
    Isabel Arrillaga-Romany
    Katherine B. Peters
    Benjamin M. Ellingson
    Marc K. Rosenblum
    Saewon Chun
    Kha Le
    Ania Tassinari
    Sung Choe
    Youssef Toubouti
    Steven Schoenfeld
    Shuchi S. Pandya
    Islam Hassan
    Lori Steelman
    Jennifer L. Clarke
    Timothy F. Cloughesy
    Nature Medicine, 2023, 29 : 615 - 622
  • [18] A PHASE 1, RANDOMIZED, PERIOPERATIVE TRIAL OF VORASIDENIB AND IVOSIDENIB IN IDH1-MUTANT DIFFUSE GLIOMA: UPDATED RESULTS
    Mellinghoff, Ingo
    Wen, Patrick
    Taylor, Jennie
    Taylor, Elizabeth
    Arrillaga-Romany, Isabel
    Ellingson, Benjamin
    Mahboub-Johnson, Paria
    Baron, Eric
    Hassan, Islam
    Steelman, Lori
    Clarke, Jennifer
    Cloughesy, Timothy
    NEURO-ONCOLOGY, 2024, 26
  • [19] Population Pharmacokinetics of Ivosidenib (AG-120) in Patients with IDH1-Mutant Advanced Hematologic Malignancies
    Le, Kha
    Wada, Russ
    Dai, David
    Fan, Bin
    Liu, Guowen
    Liu, Hua
    Attar, Eyal C.
    Agresta, Samuel V.
    Yang, Hua
    BLOOD, 2018, 132
  • [20] Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial
    Mellinghoff, Ingo K.
    Lu, Min
    Wen, Patrick Y.
    Taylor, Jennie W.
    Maher, Elizabeth A.
    Arrillaga-Romany, Isabel
    Peters, Katherine B.
    Ellingson, Benjamin M.
    Rosenblum, Marc K.
    Chun, Saewon
    Le, Kha
    Tassinari, Ania
    Choe, Sung
    Toubouti, Youssef
    Schoenfeld, Steven
    Pandya, Shuchi S.
    Hassan, Islam
    Steelman, Lori
    Clarke, Jennifer L.
    Cloughesy, Timothy F.
    NATURE MEDICINE, 2023, 29 (03) : 615 - +